Kathy Cao

Discovery of a potent and highly selective PDK1 inhibitor via fragment-based drug discovery

Daniel A. Erlanson, Joseph W. Arndt, Mark T. Cancilla et al. · Bioorganic & Medicinal Chemistry Letters · 2011 · 84 citations

Molecular Docking, Fragment-based Drug Discovery, Drug Target +6

Synthesis and SAR of novel benzoxaboroles as a new class of β-lactamase inhibitors

Yi Xia, Kathy Cao, Yasheen Zhou et al. · Bioorganic & Medicinal Chemistry Letters · 2011 · 77 citations · Full text

Medicinal Chemistry, Novel Benzoxaboroles, Biochemistry +10

Traceless Solid-Phase Synthesis of Substituted Benzimidazoles via a Base-Cleavable Linker

David Tumelty, Kathy Cao, Christopher P. Holmes · Organic Letters · 2000 · 73 citations

Diversity Oriented Synthesis, Diverse Compounds, Engineering +11

Solid-phase synthesis of substituted benzimidazoles

David Tumelty, Matthias Schwarz, Kathy Cao et al. · Tetrahedron Letters · 1999 · 45 citations

Substituted Benzimidazoles, Organic Chemistry, Synthesis Method +2